BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
BioPharm Executive - Legal Briefs
FDA Finally Proposes Social Media Guidelines For Drugmakers 6/18/2014
UK's Cost Agency Not Ready To Back Gilead Sciences, Inc. (GILD)'s Controversial Hepatitis C Drug 6/17/2014
Italy To Fund Unapproved Use Of Roche (RHHBY) Drug To Cut Costs; Move Startles The Industry 6/13/2014
Pfizer Inc. (PFE) To Pay $325 Million In Neurontin Settlement 6/3/2014
GlaxoSmithKline (GSK) Dodged Millions In China Drug Tax Scam 5/20/2014
SEC Accuses Two Doctors Of Insider Trading After GTx, Inc. (GTXI) Clinical Trial Is Halted 5/20/2014
Jury Finds For Takeda Pharmaceutical Co. Ltd. (TKPYY) In Diabetes Drug Case 5/16/2014
Eli Lilly and Company (LLY) Loses Major Patent Case To Actavis (ACT) 5/16/2014
Mylan Inc. (MYL) Applauds Court's Ruling Dismissing Teva Pharmaceutical Industries Limited (TEVA)'s Suit Against FDA On Copaxone® 5/15/2014
Ex-Sanofi (France) (SAN.PA) Executive Gets 16 Months For Insider Trading 4/21/2014
Astellas Pharma Inc. (ALPMY) Makes $7.3 Million Deal With U.S. Department Of Justice 4/17/2014
GlaxoSmithKline (GSK) Can't Catch A Break, Faces Bribery Allegations In Poland 4/14/2014
Roche (RHHBY), Novartis AG (NVS) Offices Raided Over Wet AMD Treatments 4/11/2014
Verdict In: Jury Orders Takeda Pharmaceutical Co. Ltd. (TKPYY), Eli Lilly and Company (LLY) To Pay $9 Billion In Damages Over Actos 4/8/2014
Gilead Sciences, Inc. (GILD)'s $84,000 Treatment Questioned By U.S. Lawmakers 3/25/2014
Johnson & Johnson (JNJ) Gets $1.2 Billion Risperdal Judgment Tossed Out 3/21/2014
Business Bill Could Help Scientists Let Go By Pfizer Inc. (PFE) 3/19/2014
FDA Commissioner Defends Zogenix, Inc. (ZGNX)'s Pain Drug As Criticism Intensifies 3/14/2014
Pfizer Inc. (PFE) Faces Earlier Celebrex Competition After Ruling, Vows To Appeal 3/13/2014
Maybe There Is Such A Thing As A Free Lunch - Vermont Considers Allowing Drug And Device Makers To Again Provide In-Office Meals To Healthcare Professionals 2/20/2014
Pfizer Inc. (PFE) Legal Exec Predicts Government Clampdown On CEO Quotes, Press Releases 2/14/2014
Boehringer Ingelheim Corporation Facing 2,000+ U.S. Lawsuits Over Blood Thinner 2/13/2014
Ex-SAC Trader Convicted Of Seeking Out Secrets Related To Experimental Alzheimer's Drug 2/7/2014
Abbott Laboratories (ABT) Labs Sued By Five Men Claiming Androgel Injuries 2/7/2014
Teva Pharmaceutical Industries Limited (TEVA) Asks Supreme Court To Review Copaxone Ruling 1/23/2014
Doc Admits He Leaked Secret ALZ's Trial Information To "Friend" At SAC 1/21/2014
Gentium S.p.A. Shareholders Sue Over $1 Billion Jazz Pharmaceuticals plc (JAZZ) Deal 1/17/2014
Actavis (ACT) To Exit China As Unfriendly Government Not Worth It 1/17/2014
Whistleblower Lawsuit Costs Genzyme Corporation (GENZ) $22 Million 1/6/2014
U.S. Supreme Court Refuses To Hear Ex-InterMune, Inc. (ITMN) CEO's Appeal 12/16/2013
GlaxoSmithKline (GSK) Paper At Center Of Fabricated Data Scandal Is Retracted 12/9/2013
Reckitt Benckiser Pharmaceuticals Inc. Pharma Unit In The U.S. Is Raided By The Feds 12/9/2013
European Court May Force AbbVie (ABBV), InterMune, Inc. (ITMN) To Release Business Secrets 12/6/2013
Apotex Inc. Ordered To Pony Up $76 Million To AstraZeneca PLC (AZN) In Damages 12/4/2013
U.S. Supreme Court Rejects Teva Pharmaceutical Industries Limited (TEVA)'s Copaxone Petition 11/14/2013
Sanofi (France) (SAN.PA) Files "First-Of-A-Kind" Lawsuit Against FDA Over OTC Drug 11/13/2013
FDA Slaps Aegerion Pharmaceuticals, Inc. (AEGR) CEO For "Serious" Violations Of Drug Promotion Law Following CNBC Interview 11/11/2013
Amarin Corporation PLC (AMRN) Appeals FDA Rescission of Special Protocol Agreement 11/8/2013
U.S. Appeals Court Revives Patent Fight Over AstraZeneca PLC (AZN) Drug 10/31/2013
Ex-Bristol-Myers Squibb Company (BMY) Executive Gets One Year in Prison for Insider Trading 10/24/2013
BioReference Laboratories, Inc. (BRLI) Sued by Myriad Genetics, Inc. (MYGN), Confident in Its Position 10/22/2013
Quest Diagnostics Inc. (DGX) Debuts Cheaper Genetic Test to Challenge Rival Myriad Genetics, Inc. (MYGN) 10/15/2013
Supreme Court Rejects Novartis AG (NVS) Bid to Hear Punitive Damages Case 10/8/2013
U.S. Court Lifts Ban on Competitor to AstraZeneca PLC (AZN)'s Nexium 10/2/2013
Sanofi (France) (SAN.PA) Settles Lawsuit Over Obesity Drug for $40 Million 9/20/2013
Eli Lilly and Company (LLY) Files $500 Million Lawsuit Against Canada 9/13/2013
Mold Prompts Recall of 5,000 Vials of Johnson & Johnson (JNJ)'s Schizophrenia Drug 9/13/2013
GlaxoSmithKline (GSK) Declines as FDA Clears Path for Advair Rivals, $8 Billion in Revenue Threatened 9/10/2013
Eli Lilly and Company (LLY) "Concerned" by China Bribery Allegations 9/10/2013
Federal Trade Commission Submits Proposed Amicus Brief Concerning "No-Authorized-Generic" Commitments in Drug Companies' Patent Settlements 8/20/2013
A Takeda Pharmaceutical Co. Ltd. (TKPYY) Manager Asks the Supreme Court to Review a Whistleblower Ruling 8/15/2013
OxyContin Maker, Purdue Pharma Won't Share List of Suspicious Doctors 8/13/2013
FDA Ordered to Cough Up Docs Regarding Gilead Sciences, Inc. (GILD) Drug 8/8/2013
India Revokes GlaxoSmithKline (GSK) Cancer Drug Patent in Latest Big Pharma Blow 8/2/2013
Biogen Idec, Inc. (Massachusetts) (BIIB): It's Unlikely Patient Death Was Caused by New MS Drug 7/24/2013
Novartis AG (NVS) Admits 2 Ex-Employees Plus Prominent Japanese Doc Involved in Data Scandal 7/23/2013
GlaxoSmithKline (GSK) Says Executives Appear to Have Broken Chinese Law 7/22/2013
Drugmaker Fees for FDA Review Would be Freed in U.S. House Bill 7/19/2013
SEC Comes Calling for AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) as FDA Panel Fallout Continues 7/12/2013
EU Fines H. Lundbeck A/S (LUN.CO) and Others $195 Million for Blocking Rival Drugs 6/19/2013
Novartis AG (NVS) Sacks 18 for Fabricating Sales Data 6/14/2013
The Supreme Court Rules Out Some - But Not All -- Gene Patents 6/13/2013
Another GlaxoSmithKline (GSK) Scandal in China: Bribing Docs to Prescribe Meds? 6/13/2013
Teva Pharmaceutical Industries Limited (TEVA), Sun Pharmaceutical Industries Ltd to Pay $2.15 Billion to Settle Pfizer Inc. (PFE) Patent Suit 6/12/2013
Sanofi (France) (SAN.PA) Fined $52 Million Over Plavix Smear Campaign in France 5/14/2013
Ranbaxy Laboratories (RANBAXY.BO) Pays $500 Million to Settle Long-Running Production Scandal 5/14/2013
Fired Exec Claims ReSearch Pharmaceutical Services (RPS), Inc. Violated Privacy Practices in Hiring 5/13/2013
Sanford Heisler Files $100 Million+ Discrimination Suit Against Pharma Giant Merck & Co., Inc. (MRK) 5/9/2013
Former Johnson & Johnson (JNJ) Employee Sues Over Age Discrimination 5/9/2013
Bayer AG (BAYN.DE) Patent on Yaz Birth Control Pill Ruled Invalid 4/18/2013
Amgen (AMGN) to Pay $25 Million to Settle Kickback Allegations 4/17/2013
Eli Lilly and Company (LLY) Settles Wrongful Death Lawsuit 4/10/2013
AstraZeneca PLC (AZN) Suffers Fresh Drug Patent Setback in U.S. 4/2/2013
Novartis AG (NVS) Loses Cancer Drug Glivec Patent Case 4/1/2013
Syntrix Wins $96 Million Verdict Against Illumina, Inc. (ILMN) in DNA Patent Suit 3/15/2013
Federal Trade Commission Slams Actelion Pharmaceuticals US, Inc. (ATLN.VX) for Withholding Samples 3/13/2013
Merck & Co., Inc. (MRK) Hid Fosamax's Bone-Weakening Risks, Lawyer Contends 3/13/2013
Interpol, Dozens of Drug Makers Ramp Up Fight Against Counterfeit Drugs 3/12/2013
AbbVie (ABBV) Seeks to Block Release of Clinical Trial Data 3/11/2013
Royalty Deal May Settle Lawsuit Over InterMune, Inc. (ITMN) Lung Drug 2/20/2013
Express Scripts Inc. Says Ernst & Young LLP Stole Secrets 2/20/2013
U.S. Appeals Court Finds AstraZeneca PLC (AZN)'s Seroquel XR Patent Infringed 2/15/2013
Merck & Co., Inc. (MRK) to Pay $688 Million to Settle Enhance Lawsuits 2/14/2013
Eli Lilly and Company (LLY) Threatens to Leave Canada Over Patent Rulings 2/14/2013
Amgen (AMGN) Whistleblower Fights to Unseal Documents 1/15/2013
Otsuka Can Block Generic Abilify as Court Rejects Appeal 1/15/2013
Pfizer Inc. (PFE) Can be Sued for Injury Caused by Generic 1/14/2013
Teva Pharmaceutical Industries Limited (TEVA) Asks FDA Not to Approve Biogen Idec, Inc. (Massachusetts) (BIIB) MS Drugs 1/14/2013
Eli Lilly and Company (LLY) May Have a $15 Billion "Wild Card" Up Its Sleeve: Analysis 1/7/2013
Servier Founder Faces Manslaughter Charges 12/14/2012
Pfizer Inc. (PFE) to Pay $55 Million to Settle Protonix Case 12/13/2012
KV Pharmaceutical to Pay Hologic, Inc. (HOLX) $60 Million to Settle Makena Drug Dispute 12/11/2012
Boehringer Ingelheim Corporation Sued by Hundreds Over Bleeding Tied to Pradaxa 12/11/2012
The Op-Ed: Johnson & Johnson (JNJ) Patent Move is "Inadequate" 11/30/2012
GlaxoSmithKline (GSK) Pays $90 Million to Settle States' Avandia Claims 11/16/2012
GlaxoSmithKline (GSK) Employee Blows Whistle on Drug Promotions 11/13/2012
Tiny Tekmira Pharmaceuticals Corporation Lands $65 Million Settlement Plus $10 Million in Near-Term Milestone Payments From Alnylam Pharmaceuticals (ALNY) 11/13/2012
Girl Dies as Pluristem Therapeutics (PSTI) Sells on Gains With Miracle Cells 11/9/2012
Johnson & Johnson (JNJ) Settles 845 Levaquin Lawsuits 11/2/2012
FDA Warns Celltex Therapeutics Corporation Over Violations 10/17/2012
Pfizer Inc. (PFE) to Shell Out $164 Million in Investor Lawsuit Over Celebrex 10/10/2012
Johnson & Johnson (JNJ) Loses a Preemption Case Over Infant Tylenol 10/10/2012
SEC Investigates Pfizer Inc. (PFE) Over Odd Results 10/9/2012
FDA: New England Compound Center Drugs Tied to Meningitis 10/8/2012
Johnson & Johnson (JNJ) CEO Dodges Bullet in Risperdal Drug Case 9/21/2012
Johnson & Johnson (JNJ) Settles Risperdal Side Effect Lawsuit 9/11/2012
Use of Gilead Sciences, Inc. (GILD) Stribild HIV Pill May be Limited in U.S. 9/10/2012
India Court Rules for Cipla Ltd. Against Roche (RHHBY) in Patent Case 9/10/2012
VIVUS, Inc. (VVUS) Tumbles on Concerns About Generic Qsymia 8/21/2012
Myriad Genetics, Inc. (MYGN) Wins Gene Patent Ruling From US Appeals Court 8/17/2012
Gilead Sciences, Inc. (GILD) Warned by Democrats Over "Quad" Pricing 8/16/2012
Pfizer Inc. (PFE) to Pay $60 Million for Making Foreign Bribes 8/8/2012
U.S. Appeals Court Tosses Momenta Pharmaceuticals, Inc. (MNTA) Injunction Against Generic Lovenox 8/6/2012
VIVUS, Inc. (VVUS) Diet Pill Patents are Questioned and Stock Sinks 7/23/2012
U.S. Charges 48 People in $500 Million Medicaid Drug Scheme 7/18/2012
Merck & Co., Inc. (MRK)'s Schering-Plough Corporation (SGP)'s K-Dur Pay-for-Delay Ruling Reversed 7/17/2012
K-V Pharmaceutical Company (KV-A) Sues FDA Over Makena in Fight for Survival 7/6/2012
Roche (RHHBY) Ignores 80,000 Cases of Possible Adverse Drug Reactions 7/3/2012
GlaxoSmithKline (GSK) Settles Healthcare Fraud Case for $3 Billion 7/2/2012
Abbott Laboratories (ABT) is Challenging Biotech Drug Copies, Protects Humira's Secrets 6/25/2012
Johnson & Johnson (JNJ) Close to Settling Off-Label Probes 6/21/2012
Pfizer Inc. (PFE) Paid $896 Million in Prempro Accords, Filing Shows 6/19/2012
KV Pharmaceutical : FDA Issues New Update on Makena 6/18/2012
FDA OKs Multiple Companies to Sell Generic Plavix as Drug Falls Off Patent Cliff 5/18/2012
Achillion Pharmaceuticals, Inc. (ACHN)'s Hepatitis C Drug Gets FDA Fast Track 5/15/2012
FDA Voices Caution About Popular Bone Drugs, Including Novartis AG (NVS)'s Reclast 5/11/2012
Onetime "King of Biotech" Runs Afoul of Law Again 5/11/2012
Feds Arrest Thieves Who Fleeced Eli Lilly and Company (LLY) Warehouse in $70 Million Heist 5/4/2012
Consumer Group to FDA: Pull Novo Nordisk A/S (NVO)'s Victoza Off the Market 4/23/2012
U.S. Court Invalidates Two Sanofi (France) (SAN.PA) Taxotere Patents 4/11/2012
Icahn Sues Amylin Pharmaceuticals, Inc. (AMLN) in Shake-up Try 4/10/2012
Pfizer Inc. (PFE) Execs to Stand Trial for Cover-up of Drug Trial Results 4/4/2012
FDA Finds More Fake Batches of Roche (RHHBY)'s Avastin Cancer Drug in U.S. 4/4/2012
Supreme Court Orders New Look at Gene Patents 3/26/2012
Forest Laboratories, Inc. (FRX), Johnson & Johnson (JNJ) Sue Several Drug Makers Over Bystolic 3/15/2012
Apotex Inc. Drug Maker Sues U.S. for $520 Million Under NAFTA 3/15/2012
Government Nixes Tentative $1 Billion Settlement With Johnson & Johnson (JNJ) 3/12/2012
Former FDA Chemist Gets 5 Years for Insider Trading 3/7/2012
Supreme Court Rejects Johnson & Johnson (JNJ)'s Lawsuit Over Abbott Laboratories (ABT)'s Humira 2/22/2012
Pfizer Inc. (PFE)'s Wyeth (WYE) Unit Seeks $960 Million in Damages From Sun Pharmaceutical Industries Ltd 2/20/2012
Illumina, Inc. (ILMN) Announces Favorable Patent Claim Construction Ruling in Litigation Against Complete Genomics, Inc. 2/16/2012
Roche (RHHBY) Warns of Counterfeit Avastin in the U.S. 2/16/2012
GlaxoSmithKline (GSK) Settles 20,000 Lawsuits Over Avandia, Lawyer Says 2/2/2012
Johnson & Johnson (JNJ) to Pay $158 Million to Settle Texas Risperdal Case 1/20/2012
Roche (RHHBY) Refuses to Disclose Tamiflu Data: Scientists 1/18/2012
House Democrats Probe ADHD Drug Shortage 1/18/2012
Johnson & Johnson (JNJ) to Pay $1 Billion to Settle Risperdal Marketing Probe 1/6/2012
Illumina, Inc. (ILMN) Accuses Life Technologies (LIFE) of Infringing Patent 12/29/2011
Alexza Pharmaceuticals, Inc. (ALXA) Inhaled Antipsychotic May Pose Fatal Lung Risks, FDA Review 12/9/2011
FDA Cites Violations at Three Novartis AG (NVS) Plants 12/7/2011
Roche (RHHBY) Pays $20 Million to Settle Whistleblower Lawsuit 12/2/2011
Pfizer Inc. (PFE), Teva Pharmaceutical Industries Limited (TEVA) Accused in Suit of Keeping Generic Drug Off Market 12/2/2011
Pfizer Inc. (PFE) Loses Lipitor Patent 12/1/2011
Merck & Co., Inc. (MRK) to Pay $950 Million in Vioxx Settlement 11/23/2011
'Significant' Offenses Cited at Mylan Inc. (MYL) Plant 11/23/2011
Bayer AG (BAY.F) May Have Pitched Birth-Control Pill for Unapproved Use 11/23/2011
Pfizer Inc. (PFE) Agrees to Pay $60 Million to Settle Probe into Bribes 11/21/2011
GlaxoSmithKline (GSK) to Pay $3 Billion to Settle U.S. Government Probes 11/3/2011
KV Pharmaceutical Sues Former CEO Over $37 Million in Benefits 10/17/2011
Onyx Pharmaceuticals, Inc. (ONXX), Bayer HealthCare (BAY) Restructure Oncology Agreement; Announce Settlement Reached in Litigation; Onyx Gets $160M in Settlement 10/13/2011
Bristol-Myers Squibb Company (BMY)'s Sprycel May Increase Hypertension Risk, FDA Says 10/12/2011
Pfizer Inc. (PFE) Settles with Teva Pharmaceutical Industries Limited (TEVA) Over Lipitor in UK; Deal Keeps Generic Lipitor at Bay to May 2012 10/11/2011
Teva Pharmaceutical Industries Limited (TEVA), Baxter International, Inc. (BAX), McKesson Corporation Must Pay $20 Million, Nevada Jury Says 10/7/2011
GlaxoSmithKline (GSK)'s Alli Under Review Over Liver Failure Fears 9/26/2011
Judge Orders SIGA Technologies, Inc. (SIGA) to Split Drug Profit with PharmAthene, Inc. 9/23/2011
Momenta Pharmaceuticals, Inc. (MNTA) Sues Amphastar Pharmaceuticals, Inc. for Patent Infringement 9/22/2011
Watson Pharmaceuticals, Inc. (WPI) and Sandoz, Inc. Pay $145 Million to Settle Pricing Case 9/16/2011
Baxter International, Inc. (BAX) Lawyer Taped Trying to Foil Lawsuit 8/18/2011
Amarin Corporation PLC (AMRN) Gets Final Rejection on Key Drug Patent 8/18/2011
Pfizer Inc. (PFE) Wins Viagra Patent Battle Against Teva Pharmaceutical Industries Limited (TEVA) 8/15/2011
Pfizer Inc. (PFE) Confesses About "Potential" Overseas Bribes 8/15/2011
Feds Probe Marketing of 3 Merck & Co., Inc. (MRK) Drugs 8/8/2011
Johnson & Johnson (JNJ) Blames Staff Cuts, Pfizer Inc. (PFE) Deal for Tylenol Recall Flood 7/29/2011
Amgen (AMGN) Resolves G-CSF Patent Litigation With TEVA Pharmaceuticals USA (TEVA) 7/18/2011
Gilead Sciences, Inc. (GILD) Kickstarts Patent Pool for AIDS Drugs, Agrees to Let Generic Companies like Mylan Inc. (MYL), Ranbaxy Laboratories (RANBAXY.BO) Make Them 7/12/2011
Cephalon, Inc. (CEPH) Probed by Department of Justice for Treanda (CEPH) 7/12/2011
Pfizer Inc. (PFE) Sues Aurobindo Pharma for Patent Violation 7/1/2011
Roche (RHHBY) Won't Be Forced to Disclose Ties to Avastin Backers 6/21/2011
Johnson & Johnson (JNJ) Recalling 40K Bottles of Risperdal Due to Bad Odor 6/20/2011
Johnson & Johnson (JNJ) Nabs Win in Second Levaquin Trial 6/20/2011
FDA Says Heavy Use of Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Actos May Be Tied to Bladder Cancer 6/16/2011
U.S. Investigates Gilead Sciences, Inc. (GILD)'s Drug Manufacturing And Distribution Practices 6/14/2011
More Signs Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Diabetes Drug, Actos Linked to Bladder Cancer 5/17/2011
Amylin Pharmaceuticals, Inc. (AMLN) Files Suit Against Eli Lilly and Company (LLY) 5/16/2011
Feds Seeking $1B From Johnson & Johnson (JNJ) Over Risperdal Marketing 5/13/2011
GlaxoSmithKline (GSK) May Settle 1,000 More Avandia Lawsuits, Attorney Says 5/5/2011
Ranbaxy Laboratories (RANBAXY.BO), FDA in Settlement Talks Over $1 Billion Fine 5/5/2011
Feds Seek to Oust Forest Laboratories, Inc. (FRX) CEO Solomon 4/22/2011
FDA Releases Opioid Class-Wide REMS 4/21/2011
Acorda Therapeutics (ACOR) Announces Allowance of U.S. Patent Application for AMPYRA(R) (dalfampridine) Covering Methods of Use for Improving Walking in Multiple Sclerosis 4/19/2011
Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) Reach Agreement on Arthritis Drugs; J&J Will Receive One-Time Payment of $500 Million 4/15/2011
K-V Pharmaceutical Company (KV-A) Slashes Prices Of Preterm Labor Drug After GFS Chemicals, Inc. Move 4/1/2011
AstraZeneca PLC (AZN) Lifts Profit Forecast After Agreeing Deal on U.S. Tax Payments 3/28/2011
Genzyme Corporation (GENZ) Fabrazyme Shortage to Worsen 3/24/2011
FDA Warns of Birth Defects with Use of Johnson & Johnson (JNJ)'s Topamax 3/7/2011
Japan Suspends Use of Pfizer Inc. (PFE), Sanofi-Aventis (France) (SASY.PA) Pediatric Vaccines After Four Deaths 3/7/2011
Celgene (CELG) Discloses Justice Dept Probe Into Drug Marketing 3/2/2011
Senate Bill Would Restrict Authorized Generics 2/18/2011
Momenta Pharmaceuticals, Inc. (MNTA) Scores MS Patent Victory 2/9/2011
Centers for Disease Control -- NCHS Issues Guidelines For Prescribing Truvada To Prevent HIV 2/7/2011